Literature DB >> 35771270

[Multimodal therapy for liver metastases of colorectal carcinoma in curative intention].

Hans-Michael Tautenhahn1, Sandra Nickel2, Eva Maria Kindler2,3, Utz Settmacher2.   

Abstract

Depending on the patient's constitution, the biological conditions of the primary tumor, the metastases and the liver function and perfusion, a variety of therapeutic options are available. The basis of metastatic surgery of the liver is partial liver resection. Multimodal therapies with local and systemic approaches are used in functionally or oncologically borderline situations. They are intended to improve long-term success and allow curative treatment in more patients. In recent years, for isolated lesions that cannot be removed by partial liver resection, an R0 situation is achieved in selected patients by liver transplantation with good long-term success. The large number of treatment options and the increasing individualization of therapy require treatment planning in the interdisciplinary tumor board. Also, in view of promising studies, for example, in the field of liver transplantation as well as regional therapy methods, the range of treatment options has not yet been exhausted.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Bowel cancer; Conditioning; Curative treatment; Liver metastasis; Multimodal therapy

Mesh:

Year:  2022        PMID: 35771270     DOI: 10.1007/s00104-022-01665-0

Source DB:  PubMed          Journal:  Chirurgie (Heidelb)        ISSN: 2731-6971


  1 in total

1.  Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer.

Authors:  Ilenia Bartolini; Maria Novella Ringressi; Filippo Melli; Matteo Risaliti; Marco Brugia; Enrico Mini; Giacomo Batignani; Paolo Bechi; Luca Boni; Antonio Taddei
Journal:  Gastroenterol Res Pract       Date:  2018-07-11       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.